CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); Notice of Charter Renewal, 65675 [2018-27717]
Download as PDF
Federal Register / Vol. 83, No. 245 / Friday, December 21, 2018 / Notices
FOR FURTHER INFORMATION CONTACT:
Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board
of Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782, telephone (301) 458–4303, email
isx9@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–27718 Filed 12–20–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC/HRSA Advisory Committee on
HIV, Viral Hepatitis and STD Prevention
and Treatment (CHACHSPT); Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of charter renewal.
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment (CHACHSPT), Centers for
Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through November 25, 2020.
SUMMARY:
amozie on DSK3GDR082PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Jonathan Mermin, M.D., M.P.H.,
Designated Federal Officer, CDC/HRSA
Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and
Treatment (CHACHSPT), CDC, HHS,
1600 Clifton Road, NE, Mailstop E07,
Atlanta, Georgia 30329–4027,
Telephone 404–639–8000, jhm7@
cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
00:00 Dec 21, 2018
Jkt 247001
65675
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2018–27717 Filed 12–20–18; 8:45 am]
Notice of Closed Meeting
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title
5 U.S.C., and the Determination of the
Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section (SOHSS);
National Institute for Occupational Safety
and Health (NIOSH).
Date: February 20–21, 2019.
Time: 8:00 a.m.–5:00 p.m., EST.
Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, VA 22314.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the study
section to consider safety and occupational
health-related grant applications.
For Further Information Contact: Nina
Turner, Ph.D., Scienitific Review Officer,
NIOSH, 1095 Willowdale Road, Morgantown,
WV 26506, (304) 285–5976; nturner@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–27721 Filed 12–20–18; 8:45 am]
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—PAR 13–129; NIOSH
Member Conflict Special Emphasis Panel.
Date: February 26, 2019.
Time: 12:00 p.m.–4:00 p.m. EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Nina
Turner, Ph.D., Scientific Review Officer,
Office of Extramural Programs, 1095
Willowdale Road, Morgantown, West
Virginia 26506, Telephone: (304) 285–5976;
Email: nxt2@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–27722 Filed 12–20–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
CDC/Mine Safety and Health Research
Advisory Committee (MSHRAC);
Notice of Charter Renewal
BILLING CODE 4163–18–P
PO 00000
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Public
Law 92–463. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\21DEN1.SGM
21DEN1
Agencies
[Federal Register Volume 83, Number 245 (Friday, December 21, 2018)]
[Notices]
[Page 65675]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27717]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD
Prevention and Treatment (CHACHSPT); Notice of Charter Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of charter renewal.
-----------------------------------------------------------------------
SUMMARY: This gives notice under the Federal Advisory Committee Act of
October 6, 1972, that the CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment (CHACHSPT), Centers for
Disease Control and Prevention, Department of Health and Human
Services, has been renewed for a 2-year period through November 25,
2020.
FOR FURTHER INFORMATION CONTACT: Jonathan Mermin, M.D., M.P.H.,
Designated Federal Officer, CDC/HRSA Advisory Committee on HIV, Viral
Hepatitis and STD Prevention and Treatment (CHACHSPT), CDC, HHS, 1600
Clifton Road, NE, Mailstop E07, Atlanta, Georgia 30329-4027, Telephone
404-639-8000, jhm7@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-27717 Filed 12-20-18; 8:45 am]
BILLING CODE 4163-18-P